Chargement en cours...
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
Liang Huang,1,2,* Qi Liu,2,3,* Sheng Chen,1,2 Zhiming Shao1,2 1Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3Department of Radiation Oncology, Fudan Univ...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017-12-01
|
| Collection: | OncoTargets and Therapy |
| Sujets: | |
| Accès en ligne: | https://www.dovepress.com/cisplatin-versus-carboplatin-in-combination-with-paclitaxel-as-neoadju-peer-reviewed-article-OTT |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|